CVS Health Corp

CVS: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
hdSLOCK|ZDLOCK|@>$xZJ>

CVS Health Earnings: 2026 Guidance Maintained After Strong Trends in Late 2025

In the fourth quarter, CVS turned in 8% sales growth and 8% adjusted EPS decline, or slightly higher than consensus. The firm largely confirmed targets given at its December investor day, too, albeit trimming its operating cash flow outlook to $9 billion from $10 billion after a big beat in 2025.

Sponsor Center